PanGen Biotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,756	1,430	45.4	838.28	8,901
Short-Term Investments	10,048	10,002	149.24	2	15,199
Cash & Short-Term Investments	13,804	11,432	194.65	840.28	24,100
Cash Growth	20.74%	5773.46%	-76.84%	-96.51%	28.95%
Accounts Receivable	1,574	2,959	2,208	689.81	1,089
Other Receivables	116.77	51.8	8.54	221.29	241.03
Receivables	1,690	3,261	2,330	974.1	1,393
Inventory	7,240	6,001	6,925	6,630	4,373
Prepaid Expenses	20.7	53.96	58.91	71.41	21.39
Other Current Assets	385.81	20.35	333.62	60.91	1,267
Total Current Assets	23,140	20,768	9,843	8,576	31,154
Property, Plant & Equipment	5,986	5,805	6,240	6,608	6,748
Long-Term Investments	0	0	0	0	-0
Other Intangible Assets	1,065	785.13	879.93	269.63	313.41
Long-Term Deferred Charges	1,967	2,622	3,278	3,933	4,589
Other Long-Term Assets	542.29	564.14	501.5	1,287	473.47
Total Assets	32,700	30,545	20,741	20,674	43,277
Accounts Payable	157.84	423.33	298.82	255.48	381.91
Accrued Expenses	186.02	-	-	-	-
Short-Term Debt	962.05	816.3	2,014	-	18,692
Current Portion of Leases	0.39	1.84	1.69	1.56	1.43
Other Current Liabilities	1,440	1,657	3,396	872.49	811.14
Total Current Liabilities	2,746	2,899	5,711	1,130	19,886
Long-Term Leases	-	0.39	2.24	3.93	5.49
Pension & Post-Retirement Benefits	-	2,707	2,432	2,114	2,171
Other Long-Term Liabilities	30	30	30	206.41	116.22
Total Liabilities	2,776	5,636	8,175	3,454	22,179
Common Stock	6,747	6,449	5,339	5,339	5,336
Additional Paid-In Capital	10,779	67,712	57,402	57,402	57,371
Retained Earnings	11,697	-49,953	-50,876	-46,210	-42,062
Comprehensive Income & Other	700.82	700.82	700.82	688.64	452.86
Total Common Equity	29,924	24,909	12,566	17,219	21,098
Shareholders' Equity	29,924	24,909	12,566	17,219	21,098
Total Liabilities & Equity	32,700	30,545	20,741	20,674	43,277
Total Debt	962.44	818.54	2,018	5.49	18,699
Net Cash (Debt)	12,841	10,614	-1,823	834.79	5,402
Net Cash Growth	20.99%	-	-	-84.55%	1760.05%
Net Cash Per Share	914.27	922.27	-170.76	78.21	528.69
Filing Date Shares Outstanding	13.64	12.9	10.68	10.68	10.67
Total Common Shares Outstanding	13.64	12.9	10.68	10.68	10.67
Working Capital	20,394	17,869	4,132	7,447	11,267
Book Value Per Share	2193.06	1931.18	1176.85	1612.67	1976.95
Tangible Book Value	28,859	24,124	11,686	16,950	20,784
Tangible Book Value Per Share	2114.99	1870.31	1094.44	1587.42	1947.58
Land	1,174	1,174	1,174	1,174	1,174
Buildings	3,909	3,909	3,909	3,909	3,909
Machinery	12,382	11,766	11,545	11,434	10,381
Construction In Progress	112.7	-	125.36	-	332.66

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.